1-Jul-2026
Humana, Centene lead healthcare rally in Q2 over Medicare Advantage optimism
Seeking Alpha News (Wed, 1-Jul 5:12 AM ET)
PRNewswire (Tue, 23-Jun 1:36 PM ET)
CENTENE APPOINTS LAUREN M. TYLER TO BOARD OF DIRECTORS
PRNewswire (Mon, 22-Jun 4:30 PM ET)
Modesto Residents Will Gain Access to More Affordable Homes Due to $4 Million Health Net Investment
PRNewswire (Thu, 18-Jun 2:50 PM ET)
MHS Launches Statewide Program to Help Indiana Medicaid Members with Employment
PRNewswire (Tue, 16-Jun 9:30 AM ET)
Superior HealthPlan Recognized as a Best Place for Working Parents in Texas
PRNewswire (Tue, 16-Jun 8:00 AM ET)
PRNewswire (Wed, 10-Jun 5:37 PM ET)
PRNewswire (Wed, 10-Jun 2:54 PM ET)
PRNewswire (Tue, 26-May 5:00 PM ET)
Coordinated Care and Seattle Seahawks Host Youth Mental Health Summit
PRNewswire (Tue, 12-May 2:00 PM ET)
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
Centene trades on the NYSE stock market under the symbol CNC.
As of July 1, 2026, CNC stock price climbed to $68.35 with 5,371,910 million shares trading.
CNC has a beta of 0.88, meaning it tends to be less sensitive to market movements. CNC has a correlation of 0.02 to the broad based SPY ETF.
CNC has a market cap of $33.75 billion. This is considered a Large Cap stock.
Last quarter Centene reported $50 billion in Revenue and $3.37 earnings per share. This beat revenue expectation by $2 billion and exceeded earnings estimates by $1.29.
In the last 3 years, CNC traded as high as $81.42 and as low as $25.08.
The top ETF exchange traded funds that CNC belongs to (by Net Assets): VTI, VOO, IVV, SPY, VB.
CNC has underperformed the market in the last year with a return of +20.7%, while SPY returned +22.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CNC shares. However, CNC has outperformed the market in the last 3 month and 2 week periods, returning +101.3% and +12.7%, while SPY returned +14.1% and +1.2%, respectively. This indicates CNC has been having a stronger performance recently.
CNC support price is $62.60 and resistance is $65.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNC shares will trade within this expected range on the day.